We are live on ! Find out more
CCM

Cadence Capital Management Portfolio holdings

AUM $415M
1-Year Est. Return 11.01%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
-11.01%
3 Year Est. Return
+0.72%
5 Year Est. Return
+39.08%
10 Year Est. Return
AUM
$2.09B
AUM Growth
-$289M
Cap. Flow
-$380M
Cap. Flow %
-18.22%
Top 10 Hldgs %
8.31%
Holding
697
New
113
Increased
76
Reduced
358
Closed
150

Top Buys

Rank Stock Value
1
USB icon
US Bancorp
USB
+$11.6M
2
PSX icon
Phillips 66
PSX
+$11.1M
3
MET icon
MetLife
MET
+$10.1M
4
M icon
Macy's
M
+$9.08M
5
ORLY icon
O'Reilly Automotive
ORLY
+$8.37M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$17.7M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$10.7M
3
GAP
The Gap Inc
GAP
+$8.4M
4
UAL icon
United Airlines
UAL
+$8.14M
5
SKX
Skechers
SKX
+$7.54M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.17%
2 Industrials 14.75%
3 Technology 13.58%
4 Healthcare 12.19%
5 Financials 10.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVCO icon
351
Cavco Industries
CVCO
$4.21B
$1.37M 0.07%
16,025
-1,743
-10% -$136K
ANGO icon
352
AngioDynamics
ANGO
$627M
$1.36M 0.07%
83,374
+6,125
+8% +$88.7K
PTRY
353
DELISTED
PANTRY INC (THE)
PTRY
$1.35M 0.06%
83,371
-9,201
-10% -$143K
CHUY
354
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$1.35M 0.06%
37,199
+1,240
+3% +$43.8K
CECO icon
355
Ceco Environmental
CECO
$3.99B
$1.35M 0.06%
86,311
-9,543
-10% -$146K
DYAX
356
DELISTED
DYAX CORPORATION
DYAX
$1.33M 0.06%
138,316
+14,198
+11% +$108K
LDOS icon
357
Leidos
LDOS
$14.9B
$1.32M 0.06%
34,411
+16,978
+97% +$643K
HZO icon
358
MarineMax
HZO
$774M
$1.32M 0.06%
78,621
-8,683
-10% -$137K
IRM icon
359
Iron Mountain
IRM
$36.9B
$1.31M 0.06%
40,101
-4,042
-9% -$110K
TIS
360
DELISTED
Orchids Paper Products, Inc.
TIS
$1.31M 0.06%
40,943
-4,495
-10% -$133K
CPB icon
361
Campbell Soup
CPB
$6.67B
$1.3M 0.06%
28,352
-13,614
-32% -$615K
AXS icon
362
AXIS Capital
AXS
$7.72B
$1.3M 0.06%
29,270
+2,487
+9% +$114K
JONE
363
DELISTED
Jones Energy, Inc.
JONE
$1.3M 0.06%
3,438
+458
+15% +$141K
PZN
364
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$1.29M 0.06%
115,499
-12,721
-10% -$136K
PCTI
365
DELISTED
PCTEL, Inc. Common Stock
PCTI
$1.28M 0.06%
+158,620
New +$1.25M
JMP
366
DELISTED
JMP Group LLC
JMP
$1.28M 0.06%
169,000
-18,623
-10% -$125K
USPH icon
367
US Physical Therapy
USPH
$1.18B
$1.27M 0.06%
37,241
-4,109
-10% -$133K
ROC
368
DELISTED
ROCKWOOD HLDGS INC
ROC
$1.27M 0.06%
16,657
-849
-5% -$62.4K
CBK
369
DELISTED
Christopher & Banks Corporation
CBK
$1.25M 0.06%
+143,010
New +$989K
VASC
370
DELISTED
Vascular Solutions Inc
VASC
$1.24M 0.06%
+55,650
New +$1.22M
GRC icon
371
Gorman-Rupp
GRC
$2.19B
$1.23M 0.06%
+34,890
New +$1.13M
HLIO icon
372
Helios Technologies
HLIO
$2.65B
$1.23M 0.06%
30,381
-3,359
-10% -$133K
FC icon
373
Franklin Covey
FC
$244M
$1.22M 0.06%
60,737
-18,133
-23% -$378K
EXAC
374
DELISTED
Exactech Inc
EXAC
$1.21M 0.06%
+48,010
New +$1.11M
CVGI icon
375
Commercial Vehicle Group
CVGI
$156M
$1.21M 0.06%
+120,250
New +$1.14M

Similar funds

Cadence Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Cadence Capital Management held 697 positions worth $2.09B, down 12% from $2.37B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

Cadence Capital Management withdrew a net $380M in Q2 2014, closing 150 positions and reducing 358 holdings. Its most notable exit was Alnylam Pharmaceuticals, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Industrials and Technology.

Against the trend, Cadence Capital Management opened a new position in US Bancorp worth $12.1M.

  • Cadence Capital Management's largest Q2 2014 buy was US Bancorp: 279,044 shares worth $12.1M.
  • Cadence Capital Management added most to Wynn Resorts in Q2 2014, an estimated $7.23M increase.
  • Cadence Capital Management's biggest Q2 2014 reduction was Apple, cutting an estimated $17.7M.
  • Cadence Capital Management fully exited Alnylam Pharmaceuticals in Q2 2014, selling an estimated $10.7M.
  • Cadence Capital Management's ten largest holdings make up 8.3% of its $2.09B portfolio in Q2 2014.
  • Cadence Capital Management opened 113 new positions and closed 150 in Q2 2014.
  • Cadence Capital Management's portfolio value fell 12% quarter-over-quarter to $2.09B.

Based on Cadence Capital Management's 13F filing for Q2 2014, filed 23 Jul 2014.